Progress on mTOR in eye diseases

Journal Title: Eye Science (Yanke Xuebao) - Year 2024, Vol 39, Issue 1

Abstract

Mammalian target protein of rapamycin (mTOR) is a protein kinase that primarily involves in the regulation of nutrient levels and growth metabolism in vivo. mTOR serves as a crucial target for cancer, aging, and other metabolic related pathological diseases, participating in various biological processes such as proliferation, transdifferentiation, and autophagy. The eye is considered an area with immune privilege, as the vascular system affects vision and is located outside the central light path. Many areas in the eye have mechanisms for transporting immune cells to the affected areas related to developmental, damaged, or aging. Although the immune response is primarily aimed at repairing or protecting itself, immune cells may secrete some cytokines, leading to inflammation or fibrosis, which in turn can damage vision. Results from studies have confirmed that mTOR is closely related to pterygium, age-related macular degeneration (AMD), glaucoma, cataract, diabetic retinopathy (DR), eye tumors and other eye diseases. Currently, mTOR inhibitors are widely used as immunosuppressants and approved for cancer treatment; however, there are few reports on the use of mTOR inhibitors for eye diseases. Therefore, in the article it provides a brief overview of the role, regulatory mechanisms, and drug treatment of the mTOR signaling pathway in related ophthalmic diseases, providing ideas for the pathological mechanisms and treatment of related ophthalmic diseases, in order to carry out more in-depth research in the future.

Authors and Affiliations

Yun HUA, Xinrong ZHAO

Keywords

Related Articles

Establishing nursing quality indicators for ophthalmic intra-day ward

[Objective:] To set up nursing quality indicators for ophthalmic intra-day ward, providing theoretical basis for nursing quality management in ophthalmic intra-day ward. [Methods:] Based on the "Donabedian three dimensio...

Bilateral pupil residual membrane resection combined with TICL implantation in the treatment of congenital poor vision: a case report

A 30-year-old male patient presented at our institution with a history of poor vision in both eyes since childhood, exacerbated by blurriness under bright light for over four years. Following a comprehensive ophthalmic e...

Attention should be paid to intraocular lymphoma

Intraocular lymphomas (IOL) are rare malignant neoplasms including primary intraocular lymphoma (PIOL) and secondary intraocular lymphoma (SIOL). The former is also known as primary central nervous system lymphoma (PCNSL...

Efficacy of auricular points plaster therapy on preventing gastrointestinal reaction caused by fundus fluorescein angiography

[Objective:] To explore the prevention efficacy of auricular points plaster therapy on gastrointestinal reaction caused by fundus fluorescein angiography (FFA). [Methods:] We selected 583 patients who underwent fundus fl...

Advances in artificial intelligence for cataract diagnosis

Cataract is a primary cause of blindness globally, particularly accounting for 50% of blindness cases in low- and middle-income countries. As the population ages, it is predicated that cataract blindness cases in China w...

Download PDF file
  • EP ID EP764715
  • DOI 10.12419/2312260005
  • Views 22
  • Downloads 0

How To Cite

Yun HUA, Xinrong ZHAO (2024). Progress on mTOR in eye diseases. Eye Science (Yanke Xuebao), 39(1), -. https://europub.co.uk/articles/-A-764715